PRECISE BIO’S COMPLETE GENERIC PLATFORM IS CONSISTENTLY OPTIMIZED TO LEARN AND TRANSLATE FROM ONE TISSUE TO THE NEXT TO FUEL A RICH PIPELINE OF EXCITING APPLICATIONS.

Precise Bio’s technology is designed to transform the treatment of serious diseases, and to address unmet needs in many indications. The technology overcomes multiple challenges in scalable, reproducible manufacturing of bio-printed tissues and organs.

In addition to its ophthalmic pipeline, Precise Bio is developing a 3D cardiac tissue “patch” for post myocardial infarction (MI) implant in order to retrieve cardiac muscle viability and functionality. Precise Bio’s Cardio promises to overcome the challenges of tissue vascularity and cell directionality in this potential multi-billion dollar market.

Additional indications are being evaluated in orthopedics, dental, skin, wound care and other applications.